化疗在中枢神经细胞瘤治疗中的作用。
The role of chemotherapy in the treatment of central neurocytoma.
作者信息
Johnson Margaret O, Kirkpatrick John P, Patel Mallika P, Desjardins Annick, Randazzo Dina M, Friedman Henry S, Ashley David M, Peters Katherine B
机构信息
Department of Neurosurgery, Duke University Hospital, Durham, NC 27710, USA.
Radiation Oncology, The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA.
出版信息
CNS Oncol. 2019 Nov 1;8(3):CNS41. doi: 10.2217/cns-2019-0012. Epub 2019 Nov 5.
Abstract
Central neurocytoma (CN) is a rare WHO grade II central nervous system (CNS) tumor. This is an update on chemotherapeutic agents used in its treatment. An institutional review board-approved, chart review of patients seen at our institution resulted in a single case treated with chemotherapy and is herein included. We proceeded with a comprehensive literature review. We identified 18 citations, representing 39 cases of adult and pediatric CN treated with chemotherapy. With the addition of our single case, the total number of recurrent CN patients treated with temozolomide (TMZ) is nine. There exists marked heterogeneity in chemotherapy used to treat CN. TMZ is incorporated into treatment regimens in the setting of tumor recurrence: its role merits further study.
摘要
中枢神经细胞瘤（CN）是一种罕见的世界卫生组织（WHO）II级中枢神经系统（CNS）肿瘤。本文是关于其治疗中使用的化疗药物的最新情况。通过对我院机构审查委员会批准的病例记录进行回顾，发现仅有1例患者接受了化疗，本文将其纳入。我们还进行了全面的文献综述。我们共识别出18篇文献，涵盖39例接受化疗的成人和儿童CN病例。加上我们的这例病例，接受替莫唑胺（TMZ）治疗的复发性CN患者总数为9例。用于治疗CN的化疗方案存在显著异质性。TMZ已被纳入肿瘤复发情况下的治疗方案：其作用值得进一步研究。
相似文献
1
The role of chemotherapy in the treatment of central neurocytoma.化疗在中枢神经细胞瘤治疗中的作用。
CNS Oncol. 2019 Nov 1;8(3):CNS41. doi: 10.2217/cns-2019-0012. Epub 2019 Nov 5.
2
Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.中枢神经细胞瘤伴恶性转化的临床病程——全脑全脊髓放疗的指征
Pathol Oncol Res. 2014 Apr;20(2):319-25. doi: 10.1007/s12253-013-9697-y. Epub 2013 Oct 12.
3
Diffuse central neurocytoma with craniospinal dissemination.弥漫性中枢神经细胞瘤伴颅脊髓播散。
J Clin Neurosci. 2012 Jan;19(1):163-6. doi: 10.1016/j.jocn.2011.07.016. Epub 2011 Nov 15.
4
Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue.儿童非典型中枢神经细胞瘤的治疗：大剂量化疗联合自体造血干细胞解救。
J Neurooncol. 2010 May;97(3):429-37. doi: 10.1007/s11060-009-0029-8. Epub 2009 Nov 19.
5
Chemotherapy of brain tumors.脑肿瘤的化疗
Curr Opin Neurol. 2000 Dec;13(6):619-25. doi: 10.1097/00019052-200012000-00002.
6
Chemotherapy in patients with recurrent and progressive central neurocytoma.复发性和进行性中枢神经细胞瘤患者的化疗
Cancer. 2000 Jan 1;88(1):169-74. doi: 10.1002/(sici)1097-0142(20000101)88:1<169::aid-cncr23>3.0.co;2-7.
7
Central neurocytoma: SNP array analyses, subtel FISH, and review of the literature.中枢神经细胞瘤：SNP 阵列分析、亚端粒 FISH 及文献复习。
Pathol Res Pract. 2019 Jul;215(7):152397. doi: 10.1016/j.prp.2019.03.025. Epub 2019 Mar 27.
8
Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature.儿童中枢性与脑室外神经细胞瘤：临床病理比较及文献复习
J Pediatr Hematol Oncol. 2016 Aug;38(6):479-85. doi: 10.1097/MPH.0000000000000627.
9
[Radiotherapy in central neurocytoma and review of literature].[中枢神经细胞瘤的放射治疗及文献综述]
Cancer Radiother. 2014 Jun;18(3):222-8; quiz 245, 248. doi: 10.1016/j.canrad.2013.12.006. Epub 2014 Apr 4.
10
The role of PCV chemotherapy in the treatment of central neurocytoma: illustration of a case and review of the literature.PCV化疗在中枢神经细胞瘤治疗中的作用：病例展示及文献综述
Surg Neurol. 2003 Dec;60(6):560-5. doi: 10.1016/s0090-3019(03)00252-0.
引用本文的文献
1
Treatment of Central Neurocytoma.中枢神经细胞瘤的治疗
Cancers (Basel). 2025 Jun 16;17(12):2005. doi: 10.3390/cancers17122005.
2
Outcome-associated factors in a molecularly defined cohort of central neurocytoma.分子定义的中枢神经细胞瘤队列中的预后相关因素。
Acta Neuropathol. 2025 Jun 11;149(1):61. doi: 10.1007/s00401-025-02894-3.
3
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults.年轻成人胶质神经元和神经元肿瘤的诊断和治疗的新见解。
CNS Oncol. 2024 Dec 31;13(1):2357532. doi: 10.1080/20450907.2024.2357532. Epub 2024 Jun 14.
4
Complement and coagulation cascades are associated with prognosis and the immune microenvironment of lower-grade glioma.补体和凝血级联反应与低级别胶质瘤的预后及免疫微环境相关。
Transl Cancer Res. 2024 Jan 31;13(1):112-136. doi: 10.21037/tcr-23-906. Epub 2024 Jan 29.
5
Rare Neuronal, Glial and Glioneuronal Tumours in Adults.成人罕见的神经元、神经胶质和神经胶质神经元肿瘤。
Cancers (Basel). 2023 Feb 9;15(4):1120. doi: 10.3390/cancers15041120.
6
Clinical prognostic factors for central neurocytoma and subgroup analysis of different treatment measures: A SEER database-based retrospective analysis from 2003 to 2019.中枢神经细胞瘤的临床预后因素及不同治疗措施的亚组分析：基于2003年至2019年监测、流行病学和最终结果（SEER）数据库的回顾性分析
Front Oncol. 2023 Jan 6;12:1014506. doi: 10.3389/fonc.2022.1014506. eCollection 2022.
7
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors.EANO-EURACAN-SNO 关于局限性星型细胞瘤、神经胶质神经元和神经元肿瘤的指南。
Neuro Oncol. 2022 Dec 1;24(12):2015-2034. doi: 10.1093/neuonc/noac188.
8
Long-term follow-up of lateral ventricular central neurocytoma treated with subtotal resection followed by concurrent chemoradiotherapy and add on chemotherapy - Case report from a Tertiary Kenyan Cancer Hospital.侧脑室中央神经细胞瘤次全切除术后同步放化疗及追加化疗的长期随访——来自肯尼亚一家三级癌症医院的病例报告
Surg Neurol Int. 2020 Sep 5;11:272. doi: 10.25259/SNI_389_2020. eCollection 2020.
9
Delving Inside the Enigmatic Central Neurocytoma: Electronic Hospital Database Retrieval.深入探究神秘的中央神经细胞瘤：电子医院数据库检索
Acta Inform Med. 2020 Jun;28(2):146-151. doi: 10.5455/aim.2020.28.146-151.
本文引用的文献
1
Targeting WNT Signaling for Multifaceted Glioblastoma Therapy.靶向WNT信号通路用于多方面的胶质母细胞瘤治疗
Front Cell Neurosci. 2017 Oct 13;11:318. doi: 10.3389/fncel.2017.00318. eCollection 2017.
2
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类：概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
3
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.中枢神经细胞瘤的临床结局及预后因素：二十年单中心经验
J Neurooncol. 2016 Jan;126(1):193-200. doi: 10.1007/s11060-015-1959-y.
4
Clinical course of central neurocytoma with malignant transformation-an indication for craniospinal irradiation.中枢神经细胞瘤伴恶性转化的临床病程——全脑全脊髓放疗的指征
Pathol Oncol Res. 2014 Apr;20(2):319-25. doi: 10.1007/s12253-013-9697-y. Epub 2013 Oct 12.
5
Molecular characterization of central neurocytomas: potential markers for tumor typing and progression.中枢神经细胞瘤的分子特征：肿瘤分型和进展的潜在标志物。
Neuropathology. 2013 Apr;33(2):149-61. doi: 10.1111/j.1440-1789.2012.01338.x. Epub 2012 Jul 23.
6
Prognostic factors in central neurocytomas: a multicenter study of 71 cases.中枢神经细胞瘤的预后因素：71 例多中心研究。
Am J Surg Pathol. 2012 Feb;36(2):220-7. doi: 10.1097/PAS.0b013e31823b8232.
7
Diffuse central neurocytoma with craniospinal dissemination.弥漫性中枢神经细胞瘤伴颅脊髓播散。
J Clin Neurosci. 2012 Jan;19(1):163-6. doi: 10.1016/j.jocn.2011.07.016. Epub 2011 Nov 15.
8
DNA damage response and repair: insights into strategies for radiation sensitization of gliomas.DNA 损伤反应和修复：深入了解Glioma 放射增敏策略。
Future Oncol. 2011 Nov;7(11):1335-46. doi: 10.2217/fon.11.111.
9
Neurocytomas: long-term experience of a single institution.神经细胞瘤：单机构的长期经验。
Neuro Oncol. 2011 Sep;13(9):943-9. doi: 10.1093/neuonc/nor074. Epub 2011 Aug 8.
10
Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue.儿童非典型中枢神经细胞瘤的治疗：大剂量化疗联合自体造血干细胞解救。
J Neurooncol. 2010 May;97(3):429-37. doi: 10.1007/s11060-009-0029-8. Epub 2009 Nov 19.
Zotero 插件